Green Alpha Advisors LLC Sells 883 Shares of Azenta, Inc. (NASDAQ:AZTA)

Green Alpha Advisors LLC decreased its position in Azenta, Inc. (NASDAQ:AZTA) by 8.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 9,320 shares of the company’s stock after selling 883 shares during the period. Green Alpha Advisors LLC’s holdings in Azenta were worth $466,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Kayne Anderson Rudnick Investment Management LLC grew its holdings in Azenta by 1.9% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after acquiring an additional 100,826 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the period. State Street Corp grew its stake in shares of Azenta by 0.4% in the third quarter. State Street Corp now owns 1,686,993 shares of the company’s stock worth $81,718,000 after purchasing an additional 6,398 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after purchasing an additional 183,040 shares during the period. Finally, Royce & Associates LP raised its position in Azenta by 7.8% during the 3rd quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after purchasing an additional 53,584 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Price Performance

Shares of Azenta stock opened at $51.70 on Monday. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $69.16. The company has a 50-day moving average of $47.24 and a 200 day moving average of $48.98. The firm has a market cap of $2.36 billion, a price-to-earnings ratio of -17.41 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The company’s revenue was down 1.2% on a year-over-year basis. During the same period last year, the company earned $0.13 earnings per share. On average, equities analysts anticipate that Azenta, Inc. will post 0.41 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Needham & Company LLC cut their price objective on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Evercore ISI reduced their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Finally, Stephens reaffirmed an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $61.60.

Insiders Place Their Bets

In related news, CFO Herman Cueto sold 712 shares of the company’s stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total transaction of $28,529.84. Following the completion of the sale, the chief financial officer now owns 23,892 shares in the company, valued at approximately $957,352.44. This represents a 2.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William L. Cornog bought 12,500 shares of the stock in a transaction on Monday, November 18th. The stock was purchased at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the acquisition, the director now owns 14,755 shares of the company’s stock, valued at $584,298. This trade represents a 554.32 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders sold 3,018 shares of company stock valued at $126,689. Corporate insiders own 10.62% of the company’s stock.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.